Correlation Between Day One and Artelo Biosciences
Can any of the company-specific risk be diversified away by investing in both Day One and Artelo Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Day One and Artelo Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Day One Biopharmaceuticals and Artelo Biosciences, you can compare the effects of market volatilities on Day One and Artelo Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Day One with a short position of Artelo Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Day One and Artelo Biosciences.
Diversification Opportunities for Day One and Artelo Biosciences
0.18 | Correlation Coefficient |
Average diversification
The 3 months correlation between Day and Artelo is 0.18. Overlapping area represents the amount of risk that can be diversified away by holding Day One Biopharmaceuticals and Artelo Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artelo Biosciences and Day One is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Day One Biopharmaceuticals are associated (or correlated) with Artelo Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artelo Biosciences has no effect on the direction of Day One i.e., Day One and Artelo Biosciences go up and down completely randomly.
Pair Corralation between Day One and Artelo Biosciences
Given the investment horizon of 90 days Day One Biopharmaceuticals is expected to under-perform the Artelo Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Day One Biopharmaceuticals is 1.99 times less risky than Artelo Biosciences. The stock trades about -0.09 of its potential returns per unit of risk. The Artelo Biosciences is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 114.00 in Artelo Biosciences on August 29, 2024 and sell it today you would lose (4.00) from holding Artelo Biosciences or give up 3.51% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Day One Biopharmaceuticals vs. Artelo Biosciences
Performance |
| Timeline |
| Day One Biopharmaceu |
| Artelo Biosciences |
Day One and Artelo Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Day One and Artelo Biosciences
The main advantage of trading using opposite Day One and Artelo Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Day One position performs unexpectedly, Artelo Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artelo Biosciences will offset losses from the drop in Artelo Biosciences' long position.| Day One vs. X4 Pharmaceuticals | Day One vs. Inozyme Pharma | Day One vs. Acumen Pharmaceuticals | Day One vs. Mereo BioPharma Group |
| Artelo Biosciences vs. Aileron Therapeutics | Artelo Biosciences vs. Histogen | Artelo Biosciences vs. Curis Inc | Artelo Biosciences vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |